Surface active stabilizer Tyloxapol in colloidal dispersions exerts cytostatic effects and apoptotic dismissal of cells

Toxicology and Applied Pharmacology

Volumn 232, Issue 2, 2008, Pages 218-225

  Kristl, Julijana ^a   Teskac, Karmen ^a   Milek, Miha ^a   Mlinaric Rascan, Irena ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Cell death; Cytotoxicity; Drug delivery; Nanotechnology; Solid lipid particles; Toxicological screening; Viability

Indexed keywords

BEHENIC ACID; FLUORESCENT DYE; PHOSPHOLIPID; SOLID LIPID NANOPARTICLE; TYLOXAPOL;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL FUNCTION; CELL PROLIFERATION; CELL STRAIN HEK293; CELL STRUCTURE; CELL VIABILITY; COLLOID; CYTOPLASM; CYTOSTASIS; CYTOTOXICITY; DISSOCIATION; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; INTERNALIZATION; LEUKEMIA CELL LINE; NANOTECHNOLOGY; TOXICITY TESTING;

APOPTOSIS; CELL LINE; CELL SURVIVAL; COLLOIDS; CYTOSTATIC AGENTS; HUMANS; JURKAT CELLS; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS;

EID: 52049102632     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.06.019     Document Type: Article

References (22)

1. Ahlin P., Kristl J., and Smid-Korbar J. Optimization of procedure parameters and physical stability of solid lipid nanoparticles in dispersions. Acta. Pharm. 48 (1998) 257-267
2. Egle R., Milek M., Mlinaric-Rascan I., Fahr A., and Kristl J. A novel gene delivery system for stable transfection of thiopurine-S-methyltransferase gene in versatile cell types. Eur. J. Pharm. Biopharm. 69 (2008) 23-30
3. Gursoy N., Garrigue J.S., Razafindratsita A., Lambert G., and Benita S. Excipient effects on in vitro cytotoxicity of a novel paclitaxel self-emulsifying drug delivery system. J. Pharm. Sci. 92 (2003) 2411-2418
4. Kayser O., Lemke A., and Hernandez-Trejo N. The impact of nanobiotechnology on the development of new drug delivery systems. Curr. Pharm. Biotechnol. 6 (2005) 3-5
5. Kristl J., Volk B., Ahlin P., Gombac K., and Sentjurc M. Interactions of solid lipid nanoparticles with model membranes and leukocytes studied by EPR. Int. J. Pharm. 256 (2003) 133-140
6. Kukowska-Latallo J.F., Chen C., Eichman J., Bielinska A.U., and Baker J.R. Enhancement of dendrimer-mediated transfection using synthetic lung surfactant exosurf neonatal in vitro. Biochem. Biophys. Res. Commun. 14 (1999) 253-261
7. Kuo J.H., Jan M.S., and Chiu H.W. Cytotoxic properties of Tyloxapol. Pharm. Res. 23 (2006) 1509-1516
8. Mehnert W., and Mäder K. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 47 (2001) 165-196
9. Mlinaric-Rascan I., and Turk B. B cell receptor-mediated nuclear fragmentation proceeds in WEHI 231 cells in the absence of detectable DEVDase and FRase activity. FEBS Lett. 553 (2003) 51-55
10. Murn J., Urleb U., and Mlinaric-Rascan I. Internucleosomal DNA cleavage in apoptotic WEHI 231 cells is mediated by a chymotrypsin-like protease. Genes Cells 9 (2004) 1103-1111
11. Müller R.H., Ruhl D., Runge S., Schulze-Foster K., and Mehnert W. Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharm. Res. 14 (1997) 458-462
12. Olbrich C., Schöler N., Tabatt K., Kayser O., and Müller R.H. Cytotoxicity studies of Dynasan 114. solid lipid nanoparticles (SLN) on RAW 264.7 macrophages-impact of phagocytosis on viability and cytokine production. JPP 56 (2004) 883-891
13. Patnode R.A., Hudgins P.C., and Janicki B.W. Studies on the effect of Triton (WR-1339) on guinea pig tissues. J. Exp. Med. 107 (1958) 33-61
14. Schubert M.A., and Müller-Goymann C.C. Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier. Eur. J. Pharm. Biopharm. 61 (2005) 77-86
15. Staub N.C., Longworth K.E., Serikov V., Jerome E.H., and Elsasser T. Detergent inhibits 70-90% of responses to intravenous endotoxin in awake sheep. J. Appl. Physiol. 90 (2001) 1788-1797
16. Unfried K., Albrecht C., Klotz L.O., Von Mikecz M., Grether-Beck S., and Schins R. Cellular responses to nanoparticles: target structures and mechanisms. Nanotoxicology 1 (2007) 52-71
17. Van Kooten T.G., Klein C.L., Kohler H., Kirkpatrick C.J., Williams D.F., and Eloy R. From citotoxicity to biocompatibility testing in vitro: cell adhesion molecule expression defines a new set of parameters. J. Mater. Sci. Mater. Med. 8 (1997) 835-841
18. Weg G.J., Bulk R.A., Tharratt R.S., Jenkinson S.J., Jagdip J.B., Zaccardelli D., Horton J., and Pattishall E.N. Safety and potential efficacy of an aerosolized surfactant in human sepsis-induced adult respiratory distress syndrome. JAMA 272 (1994) 1433-1438
19. Westesen K., Bunjes H., and Koch M.H.J. Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J. Control. Rel. 48 (1997) 223-236
20. Wissing S.A., Kayser O., and Müller R.H. Solid lipid nanoparticles for parenteral drug delivery. Adv. Drug Del. Rev. 56 (2004) 1257-1272
21. Zhanga Z., and Fenga S. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials 27 (2006) 4025-4033
22. Zhao Y., and Nalwa H.S. Cellular responses to nanoparticle exposure. In: Nanotoxicology - Interactions of nanomaterials with biological systems (2007), American Scientific Publisher, Valencia, CA 64-100